Fabtech Technologies Cleanrooms Limited has announced that its board of directors has approved the incorporation of a wholly-owned subsidiary in the United Arab Emirates (UAE). This strategic decision aims to expand the company's pharmaceutical equipment manufacturing and trading operations in the region.

Subsidiary Details

The key details of the proposed subsidiary are as follows:

The new entity will be incorporated under the name Fabtech Technologies Cleanrooms-FZE, subject to approval by UAE regulatory authorities.

Business Objectives

The subsidiary will focus on the manufacturing and trading of pharmaceutical equipment. Its primary objectives include:

1. Serving as a turnkey project solutions provider and manufacturer of pharmaceutical machineries, including sterilite, LAF (Laminar Air Flow), modular cleanroom equipment, and chemical equipment used in pharmaceutical projects.

2. Engaging in various activities such as:

   • Manufacturing, designing, researching, and developing pharmaceutical equipment
   • Assembly, installation, and reconditioning of cleanroom systems
   • Import, export, and distribution of related products
   • Acting as agents, brokers, and representatives for pharmaceutical equipment
   • Dealing in automatic, semi-automatic, and manual pharmaceutical machineries
   • Providing laboratory equipment and analytical instruments
   • Supplying air handling units and bio-air conditioning systems

Strategic Implications

This expansion into the UAE market demonstrates Fabtech Technologies' commitment to growing its international presence in the pharmaceutical equipment and cleanroom solutions sector. The subsidiary will enable the company to better serve clients in the Middle East region while leveraging the UAE's strategic location as a business hub.

The incorporation of the subsidiary is subject to approval from UAE regulatory authorities. Upon incorporation, it will become a related party of Fabtech Technologies Cleanrooms Limited.

This development represents a significant step for Fabtech Technologies as it seeks to strengthen its position in the global pharmaceutical equipment market and expand its operational footprint in the Middle East.

Fabtech Technologies Cleanrooms Ltd. has reported a strong order inflow for October 2025, showcasing its growing presence in key industrial sectors. The company, which specializes in cleanroom and HVAC solutions, has secured consolidated orders worth ₹9.26 crore during the month, demonstrating its ability to capture opportunities across diverse industries.

Order Breakdown by Sector and Business Vertical

The order inflow reflects Fabtech's strong positioning in the pharmaceutical sector, which contributed the largest share at ₹6.55 crore. The data centre segment also showed significant traction with orders worth ₹2.68 crore.

Robust Order Book Position

As of October 31, 2025, Fabtech Technologies Cleanrooms Ltd. reported a consolidated order book of ₹165.16 crore, distributed across various sectors:

This diverse order book underscores the company's strategic focus on high-growth industries, particularly in renewable energy and pharmaceuticals.

Future Growth Prospects

Fabtech Technologies Cleanrooms Ltd. has indicated a strong pipeline of potential orders under active consideration, totaling ₹477.86 crore. The breakdown of these opportunities is as follows:

The substantial potential in renewable energy and semiconductors sectors signals the company's alignment with emerging industry trends and its capability to cater to advanced manufacturing facilities.

Fabtech Technologies Cleanrooms Ltd. continues to build momentum in the renewable energy and pharmaceutical sectors, reflecting its strategic diversification across high-growth industries. The company's ability to deliver integrated cleanroom and HVAC solutions positions it well to capitalize on the growing demand for advanced manufacturing facilities across various sectors.

Investors and market watchers may find Fabtech's order inflow and robust order book encouraging, as it indicates the company's potential for sustained growth in the coming quarters. However, it's important to note that the realization of potential orders and future performance will depend on various market factors and the company's execution capabilities.